-
collection of research (particularly trial) data from out-of-hospital settings, which will then help to inform future studies as best practice. The PhD may include: Evidence synthesis in how outcome data is
-
approach to real drug targets in cancer, working at the interface of synthetic chemistry and biology to help speed up the discovery of new medicines. You will join an established, successful, integrated drug
-
mitochondrial biology, a highly specialised clinical service, human genetics, proteomics, bioinformatics and translational science. You will be supervised by Professor Rob Taylor, Dr Sarah Pickett and Professor
-
scientists. Number of awards: 1 Start date: 04/01/2027 Award duration: 4 years Sponsor MDUK Supervisors Dr Philipp Heher Dr Ana Töpf Professor Volker Straub Eligibility criteria A 2:1 honours degree
-
Professor Judith Rankin Population Health Sciences, Newcastle University Email: [email protected] If you have any technical queries about submitting your application via the Apply to Newcastle
-
-ready innovation. Number of awards: 1 Start date: September 2026 Award duration: 3 years full-time Sponsor: Newcastle University Supervisors: Professor Dawn Craig, Newcastle University Professor Paul